Volume 1, Issue 1
Company to Watch: Biosome

Biosome has several meetings with potential investors scheduled.  The Delaware Strategic Fund of the State of Delaware has agreed to grant Biosome a $375,000 loan to expand its nanotechnology business in Delaware.  The company is currently evaluating this and other financing options.  Biosome was founded in 1997 as a part of Analytic Biological Services (ABS) inc. and will be an independent spin-off later this year.  

For more information about Biosome, please visit ABS’ website at  www.absbio.com.

ESE Would Like to Thank All of our Bio-Life-Tech Princeton Sponsors
Early Stage East would like to send out a sincere thank you to all of the organizations that sponsored Bio-Life-Tech Princeton. Thanks to all of you, the event was a complete success. Twelve of the area’s most promising biotechnology and life science companies made impressive presentations that received very positive feedback from the attendees. Aspiring entrepreneurs were brought together with many investors and professionals and given the ability to network with these individuals and further their businesses. Early Stage East would like to give special thanks to all of our sponsors involved in coaching, selection, and panel discussions. Without your hard work none of this would be possible. Thank you! The sponsors for Bio-Life-Tech Princeton include: Pepper Hamilton, LLP, Duane Morris, LLP, Saul Ewing, LLP, Fox Rothschild, LLP, SMART & Associates, Morgan, Lewis & Bockius, LLP, Ballard Spahr Andrews & Ingersoll, LLP, Ernst & Young, LLP, Ratner Prestia, P.C., Delaware Innovation Fund, Commerce Health Care Ventures, FedEx, McBride Shopa & Company, P.A., the State of NJ, the State of MD(DBED), and TEDCO.
Volume 1, Issue 1
January 19, 2007

Early Stage East was an excellent opportunity for making new contacts and providing exposure for our company.

Chrales F. Saller
President & CEO





Early Stage East’s Bio·Life·Tech is the region’s premier forum for young life science companies,” says Steve Simpson, a partner in the Strategic Growth Markets Practice of Ernst & Young.








To remove your name from our mailing list, please click here.
Questions or comments? E-mail us at [email protected] or call (302) 777-2460.